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Inflammation is one of the earliest processes 
used during an innate immune response in an 
attempt to expel pathogens. Recognition of 
conserved pathogen-associated molecular pat-
terns (PAMPs) by pattern recognition recep-
tors, such as Toll-like receptors (TLRs), on 
resident cells and recruited phagocytes initiates 
a signaling cascade that leads to a local inflam-
matory response, including the production of 
cytokines and chemokines, vasoactive peptides, 
complement, and reactive oxygen species (Takeda 
and Akira, 2005).
By activating APCs, TLR-driven inflamma-
tion also controls the development of adaptive 
immune responses (Akira et al., 2001; Schnare 
et al., 2001; Iwasaki and Medzhitov, 2004). De-
velopment and polarization of antigen-specific 
T and B cells is a well recognized function of 
PAMP-activated APCs (Iwasaki and Medzhitov, 
2004; Pasare and Medzhitov, 2005). Recently, it 
was discovered that cells of the adaptive im-
mune system provide additional signals to either 
restrict host inflammatory processes or con-
tribute to protective inflammation and host 
defense. During viral infection, naive T cells 
were shown to limit mortality by dampening 
lethal innate immune system–mediated inflam-
mation (Kim et al., 2007). Similarly, memory 
and effector T cells were found to suppress 
inflammasome-mediated inflammation by block-
ing activation of NALP1 and NALP3 (Guarda 
et al., 2009). More recently, however, memory 
T cells were shown to contribute to influenza-
induced innate inflammatory cytokine and che-
mokine (IIC) production resulting in improved 
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Microbes activate pattern recognition receptors to initiate adaptive immunity. T cells affect 
early innate inflammatory responses to viral infection, but both activation and suppression 
have been demonstrated. We identify a novel role for B cells in the early innate immune  
response during bacterial sepsis. We demonstrate that Rag1/ mice display deficient early 
inflammatory responses and reduced survival during sepsis. Interestingly, B cell–deficient or 
anti-CD20 B cell–depleted mice, but not / T cell–deficient mice, display decreased inflam-
matory cytokine and chemokine production and reduced survival after sepsis. Both treatment 
of B cell–deficient mice with serum from wild-type (WT) mice and repletion of Rag1/ mice 
with B cells improves sepsis survival, suggesting antibody-independent and antibody-dependent 
roles for B cells in the outcome to sepsis. During sepsis, marginal zone and follicular B cells are 
activated through type I interferon (IFN-I) receptor (IFN-/ receptor [IFNAR]), and repleting 
Rag1/ mice with WT, but not IFNAR/, B cells improves IFN-I–dependent and –independent 
early cytokine responses. Repleting B cell–deficient mice with the IFN-I–dependent chemokine, 
CXCL10 was also sufficient to improve sepsis survival. This study identifies a novel role for  
IFN-I–activated B cells in protective early innate immune responses during bacterial sepsis.
© 2011 Kelly-Scumpia et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons.
org/licenses/by-nc-sa/3.0/).
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immunity affects the systemic inflammatory response to sep-
sis. In WT mice, 6 h after CLP, the production of IIC in sera, 
including IL-1, IL-1, IL-6, IL-10, KC (IL-8 homologue), 
TNF, RANTES, and MCP-1, peaked before decreasing at 18 h 
(Fig. 1 B; IL1 not depicted). Of note, sepsis did not in-
crease plasma cytokine concentrations not associated with a 
systemic inflammatory response, including IL-2, IL-3, IL-4, 
IL-7, IL-9, IL-15, IL-17, G-CSF, GM-CSF, and VEGF-A, in 
WT mice (unpublished data). Interestingly, IIC concentra-
tions remained low in Rag1/ mice at both 6 and 18 h after 
CLP and were significantly lower at 6 h (Fig. 1 B). These data 
suggest that cells of the adaptive immune system are contrib-
uting to early inflammation after bacterial sepsis.
B cell–deficient MT/ mice, but not TCR-deficient mice, 
display decreased IIC production and decreased survival 
after sepsis
To investigate whether T or B cells were contributing to 
IIC production in sepsis, we performed CLP in T cell–
 deficient TCR-// and B cell–deficient MT/ mice. 
viral clearance (Strutt et al., 2010). These studies suggest that 
the adaptive immune system provides important feedback 
during acute inflammatory processes to provide host defense 
or limit pathology. However, little is known about how the 
adaptive immune system affects innate immunity during bac-
terial sepsis.
Bacterial sepsis is a scenario where pathological inflam-
mation may lead to unwanted organ injury. In septic hosts, an 
exaggerated inflammatory response leads to sustained sys-
temic inflammation, which contributes to failure to clear pri-
mary pathogens by causing defective innate and adaptive 
immune responses. Interestingly, Rag1/ mice deficient in 
adaptive immunity demonstrate increased mortality after bac-
terial sepsis (Hotchkiss et al., 1999, 2000). Treatment of these 
mice with transgenic lymphocytes that are resistant to apop-
tosis was shown to improve survival (Hotchkiss et al., 1999), 
but which component of adaptive immunity regulates out-
come is currently unknown.
In this study, we find, in response to bacterial sepsis, that 
mice devoid of an adaptive immune system actually demon-
strate an attenuated and not an exaggerated inflammatory re-
sponse. We find that deficiency of B cells, and not T cells, can 
completely replicate this phenotype and B cells contribute to 
inflammatory cytokine responses in vitro and in vivo. We also 
find that the mechanism of B cell activation in response to 
bacterial sepsis involves type I IFN (IFN-I) and redundant 
TLR signaling.
B cells produce inflammatory cytokines in vitro and 
in vivo and repletion of Rag1/ mice with B cells improves 
survival, demonstrating that B cell function in the absence of 
T cell–dependent antibodies is important for sepsis outcome. 
Interestingly, mice deficient in B cells produce decreased levels 
of IFN-I–dependent cytokines. Treatment of Rag1/ mice 
with the IFN inducible chemokine CXCL10 after sepsis ini-
tiation also improves outcome, and repletion of Rag1/ 
mice with WT but not IFN-/ receptor (IFNAR)/  
B cells restores IFN dependent and independent cytokine 
production. This study identifies a novel role for IFN-regulated 
B cells in modulating early innate immune responses during 
bacterial sepsis and identifies B cells as participants in a pro-
tective IFN-I–dependent circuit during sepsis.
RESULTS
Adaptive immune deficiency results in a decreased early 
inflammatory response and increased mortality during sepsis
As mice deficient in their adaptive immune system were pre-
viously shown to succumb more readily to bacterial sepsis 
(Hotchkiss et al., 1999, 2000), we first wished to determine 
how loss of the adaptive immune system was affecting early 
innate immune responses during bacterial sepsis. We confirm 
that Rag1/ mice (mice deficient in B and T cells) are in-
deed highly susceptible to cecal ligation and puncture (CLP) 
lethality (Fig. 1 A; Fisher’s exact test, P = 0.0001). Because the 
adaptive immune system has been shown to either augment 
or inhibit IIC production to viral challenge (Guarda et al., 
2009; Strutt et al., 2010), we examined how loss of adaptive 
Figure 1. Adaptive immune effector cells are needed for survival to 
CLP-induced sepsis as well as the inflammatory response. (A) Rag1/ 
mice (open circles; n = 21) and WT mice (closed diamonds; n = 12) were 
subjected to CLP and monitored for survival (P < 0.001). (B) Serum was 
collected at 0, 6, and 18 h after CLP from Rag1/ mice (white bars) and WT 
animals (black bars), and cytokines were measured by Luminex multiplex 
analysis. Experiments in A were performed four separate times with n ≥ 6 
mice per group. The combined results from two independent experiments 
are shown. Experiments in B were performed two independent times with  
n ≥ 4 per group. Shown in B are mean values + standard deviation.  
*, P < 0.05; Ŧ, P < 0.001 by Student’s t test comparing WT with Rag1/ mice.
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B cells can contribute to cytokine production within a mixed 
cell population toward an inflammatory stimulus.
B cell depletion leads to decreased IIC production
To ensure that the lack of an inflammatory response in 
Rag1/ and MT/ mice was a result of the absence of 
B cells and not the absence of antibodies, which can lead to 
inflammatory cytokine production by the cross-linking of 
FcR on phagocytes, we chose to use a different model of 
B cell depletion. Anti-CD20 antibodies have been used in mice 
and humans to deplete CD20-expressing mature lympho-
cytes in leukemia/lymphoma as well as in autoimmune con-
ditions. This results in the depletion of mature B cells that 
express CD20, but the majority of antibody production by 
plasma cells remains intact. Treatment of mice with 10 mg/kg 
anti-CD20 antibody resulted in 70% depletion of B220+ 
CD19+ lymphocytes in the blood and spleen over isotype 
control antibody-treated mice 7 d after IP injection (un-
published data). Before CLP, 7 d after injection of the anti-
CD20 or isotype control antibody, serum levels of total IgA 
and IgG3 were increased in anti-CD20–treated mice, whereas 
no difference was detected in serum levels of IgM, IgG1, or 
IgG2c between the two groups. The only antibody that was 
significantly lower in anti-CD20–treated mice than isotype 
control-treated mice was IgG2b. 18 h after CLP, levels of IgM, 
IgG1, IgG2b, and IgG2c were similar between both groups, but 
levels of IgG3 and IgA remained higher in anti-CD20–treated 
mice (Fig. 3 A). This suggests that if changes in cytokine levels 
exist, the difference can be attributed to the lack of or pres-
ence of B cells and not to differences in antibody levels be-
tween groups. Using a 10-cytokine Luminex array, we found 
that anti-CD20 treatment depletion of 70% of mature 
B cells led to significant reductions in IL-6, IL-10, and MIP-1 
concentrations 6 h after CLP (Fig. 3 B). When data from three 
separate experiments was combined, we found that IFN-, 
IP-10, MCP-1, and KC were also significantly lower in anti-
CD20–treated mice, whereas TNF, IL-1, and IL-12p70 levels 
were not different between groups (unpublished data). These 
data show that depletion of a large portion, but not all, of 
mature B cells in the face of near normal serum immuno-
globulin levels is sufficient for a diminished early IIC response 
after sepsis. The fact that a few IICs did not differ between the 
groups suggests either that FcR cross-linking of antibodies 
on phagocytes may also contribute to the production of cer-
tain cytokines or that the presence of the remaining fraction 
of undepleted mature B cells (30%) may be sufficient to allow 
the production of certain IICs.
Because lymphocyte IIC production was shown to con-
tribute to viral clearance after influenza infection (Strutt 
et al., 2010), it may also contribute to bacterial clearance 
during sepsis. We next analyzed whether MT/ mice dis-
play defective bacterial clearance. At 18 and 48 h after sepsis, 
MT/ mice demonstrate an impaired ability to clear bac-
teria from the peritoneum (Fig. 2 C), indicating that the 
presence of B cells is required for optimal bacterial clear-
ance during sepsis.
Interestingly, we found that TCR-// mice display a 
modest but insignificant decrease in IIC production after sep-
sis (Fig. S1 A) and also do not display an increased susceptibil-
ity to sepsis-induced mortality when compared with WT 
mice (Fig. S1 B). Sepsis in MT/ mice, however, results in 
significant defects in IIC induction and increased mortality 
(Fig. 2, A and B), similar to Rag1/ mice. These data sug-
gest a novel and previously unrecognized role of B cells in 
regulating innate immune responses and, thus, the remainder 
of our investigations focused on the role of B cells in sepsis.
B cells can produce immunoregulatory cytokines, such as 
IL-6 or IL-12, upon TLR4 or TLR9 ligation (Hobbs et al., 
1991; Yi et al., 1996; Sun et al., 2005), but whether they can 
contribute to IIC production in vitro has not been investigated 
in detail. We find that LPS stimulates Rag1/ splenocytes to 
produce IL-6, and the addition of equal numbers of B cells 
results in a near doubling of IL-6 levels (Fig. S2), suggesting that 
Figure 2. B cells are important for the cytokine response to CLP- 
induced sepsis and contribute to decreased bacteremia. (A) Serum was 
collected at 0, 6, and 18 h after CLP from MT/ mice (white bars) and WT 
animals (black bars), and cytokines were measured by Luminex multiplex analy-
sis. The experiment was performed at least twice with n ≥ 4 per group. Error 
bars represent standard deviation. (B) WT (closed diamonds; n = 22) and 
MT/ (open squares; n = 24) mice were subjected to CLP and monitored for 
survival (P = 0.004). Shown are the combined results of two independent  
experiments with n ≥ 10 per group. (C) Bacterial counts were measured in the 
peritoneal washings of WT and MT/ mice 12, 18, or 48 h after CLP. The 
experiment was performed three independent times with an n ≥ 3 per group. 
Shown in B and C are mean values + standard deviation. *, P < 0.05;  
Ŧ, P < 0.001 by students t test comparing WT with MT/ mice.
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migrate to the T cell follicle (Lu and Cyster, 2002; Karlsson 
et al., 2003; Rubtsov et al., 2008) or they can develop into 
plasma cells to produce rapid but low-affinity IgM antibody 
(Martin et al., 2001; McHeyzer-Williams, 2003). Follicular 
B cells classically respond to T cell–dependent antigen and 
require a longer time to develop into plasma cells as they require 
T cell help. Not surprisingly, when examining peritoneal 
B1 cells, we find that the majority (>90%) of peritoneal B1a 
(B220+CD11b+CD5) and B1b (B220+CD11b+CD5) cells 
are depleted from the peritoneal cavity within 36 h after sepsis, 
concomitant with a dramatic increase in peritoneal neutro-
phil (Gr-1+CD11b+) influx (unpublished data). As peritoneal 
Bacterial sepsis activates B cells
Because B cells are playing a pivotal role during sepsis, we 
next wished to examine how sepsis affects B cells. We find 
that as early as 24 h after CLP-induced sepsis, total B220+CD19+ 
cells display an increase in CD69 expression in the spleen, 
BM, and mesenteric lymph nodes (Fig. 4, A and B; and not 
depicted). This activation state decreases by day 3 after sepsis 
but again increases through 10 d (unpublished data).
Multiple B cell populations have different capacities to 
respond to antigens. Peritoneal B1 cells and marginal zone 
(MZ) B cells are responsible for most natural antibody pro-
duction, which provides broad protection against a limited 
array of antigens such as LPS (Martin et al., 2001; McHeyzer-
Williams, 2003; Yang et al., 2007). MZ B cells classically are 
the first B cells to encounter blood-borne pathogens, as they 
are located adjacent to splenic marginal sinuses where macro-
phages and dendritic cells trap antigens (Martin et al., 2001; 
McHeyzer-Williams, 2003). During Staphylococcus aureus in-
fection or TLR stimulation, MZ B cells are also known to 
Figure 3. Depletion of B cells with anti-CD20 antibody decreases 
cytokine production after sepsis. C57BL/6 mice were treated intraperito-
neally with 10 mg/kg anti-CD20 or isotype control antibody, and blood was 
obtained 7 d later, followed by CLP. 6 and 18 h after CLP, mice were bled 
again. (A) Before CLP (Pre) and 18 h after CLP (Post), serum was obtained 
and concentrations of IgM (top left), IgG1 (top middle), IgG2a (top right), 
IgG2c (bottom left), IgG3 (bottom middle), and IgA (bottom right) were 
quantified by ELISA. (B) 6 and 18 h after CLP, plasma was obtained and 
cytokine production was examined by Luminex. Experiments were per-
formed three independent times with n ≥ 3 per group. The data shown are 
from a single representative experiment with n = 4 per group. *, P < 0.05; 
Ŧ, P < 0.001 by Students t test CLP with isotype control versus CLP with anti-
CD20 antibody treatment. Error bars represent standard deviation.
Figure 4. B cells are activated early after CLP. (A and B) Representa-
tive flow plots of the spleen (A, top left) and BM (B, top right) showing 
CD69 expression on B220+ B cells after CLP. Graphs show the percentage 
of B220+CD69+ in the spleen (bottom left) and BM (bottom right). *, P < 0.05 
by Students t test comparing Sham with CLP mice. n = 4 per group. (C) Rep-
resentative flow diagrams showing the gating strategy for MZ (B220+IgM+ 
IgDCD21+CD23lo) and follicular (Fo; B220+IgD+IgMloCD23hi) B cells in the 
spleen 24 h after CLP or Sham treatment (left). The graph shows the total 
number of live MZ and follicular B cells in the spleen 24 h after Sham or 
CLP surgery (right). (D) Representative flow plots of activated (CD69+) MZ 
and follicular B cells (left). The graph shows the percentage of activated  
B cells 24 h after Sham or CLP treatment (right). Experiments were per-
formed three independent times with n ≥ 3 per Sham group and an  
n = 4 per CLP group. *, P < 0.05; Ŧ, P < 0.001 by Students t test comparing 
Sham with CLP treatment. Error bars represent standard deviation.
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using mice deficient in IFNAR/, the sole receptor responsi-
ble for IFN-I signaling. We find that CD69 expression is signi-
ficantly decreased in mice deficient in IFNAR/ compared 
with WT controls (Fig. 5 B), highlighting the role of IFN-I 
during sepsis-induced B cell activation.
Antibody-independent B cell functions are integral  
for sepsis outcome
The role of B cells in autoimmunity and infectious disease 
includes both antibody-dependent and antibody-independent 
functions (Chan et al., 1999; Leef et al., 2000; Lampropoulou 
et al., 2010). In MT/ mice, the production of the major-
ity of immunoglobulins is severely impaired as a result of the 
deletion of the  region of the immunoglobulin locus (Kitamura 
et al., 1991), but IgA and IgE secretion still occurs (Macpherson 
et al., 2000). As B cell production of antibodies against com-
mensal organisms provides protective immunity in innate 
immunodeficient mice (Slack et al., 2009), and the CLP model 
induces sepsis using commensal microorganisms, we wished 
to determine whether antibody-dependent or -independent 
functions of B cells provide protective immunity during CLP-
induced sepsis. Treatment of MT/ mice with sera from 
WT mice 2 h before sepsis from normal mice partially im-
proves sepsis survival (Fig. 6 A).
To determine if an antibody-independent role of B cells 
contributes to survival during sepsis, Rag1/ mice were 
given 107 B220+ splenic B cells and were subjected to CLP 
2 d later. Approximately 90% of these B cells are of the B2 or 
conventional B cell lineage. We find that treatment of 
B1 cells migrate to the spleen and lymph nodes after activa-
tion, we examined whether septic mice display an increase in 
splenic B1 cells or splenic B1 cell activation. We find a small 
(<50%) increase in B220+CD11b+ B1 cells in the spleen. 
However, these cells make up <10% of the total splenic B cell 
population and do not display an increased activation state, as 
determined by CD69 expression, and so were likely not con-
tributing to the increased CD69 expression within splenic 
CD19+B220+ cells (unpublished data). When we analyzed the 
effects of sepsis on other B cell subtypes in the spleen, we find 
a reduction in both MZ (B220+IgM+IgDCD21+CD23lo) 
and follicular B cell populations (B220+IgD+IgMloCD23hi), 
with a more pronounced depletion of MZ B cells, within 24 h 
(Fig. 4 C). The remaining MZ and follicular B cells demonstrate 
a seven- and fivefold increase in CD69 expression (Fig. 4 D), 
demonstrating that sepsis activates both cell populations, sug-
gesting that B cell maturation progresses well during sepsis.
Because sepsis activates both MZ and follicular B cells, 
and either cell type can contribute to germinal center reac-
tions or become antibody-secreting plasmablasts and plasma 
cells in the presence of TLR agonists or infections (de Vinuesa 
et al., 2000; McHeyzer-Williams, 2003; Song and Cerny, 
2003; Rubtsov et al., 2008; Swanson et al., 2010), we next 
examined whether sepsis induces germinal center B cell 
and plasma cell development. Within 7 d, there is a dramatic 
increase in both B220+GL7+IgDlo germinal center B cells and 
CD138+IgD/low plasmablast/plasma cell formation (unpub-
lished data). These data show that sepsis rapidly activates MZ 
and follicular B cells and induces both germinal cell reaction 
and plasma cell formation.
B cell activation during sepsis occurs in the absence  
of TLR pathways
We next wished to examine the pathways contributing to 
sepsis-induced B cell activation. Many pathways are activated 
during sepsis, including MyD88-dependent and -independent 
TLR signaling and IFN-I–dependent pathways which may 
result in B cell activation. In fact, B cell–intrinsic MyD88 
signaling was shown to amplify early antibody responses 
(Meyer-Bahlburg et al., 2007). We first determined whether 
TLR pathways contribute to early B cell activation using 
MyD88/ and TRIF/ mice. We find that deficiency of 
either pathway had no effect on increased B cell CD69 ex-
pression (Fig. 5 A). These data suggest that TLR signaling is 
redundant in sepsis-induced B cell activation.
B cell activation during sepsis requires IFN-I
Because TLR signaling through MyD88 or TRIF was playing 
a partial or redundant role, we examined whether other im-
mune pathways may be participating in sepsis-induced B cell 
activation. IFN-I is a pleiotropic cytokine that provides crucial 
signals to B cells. Recently, the TLR3 agonist double-stranded 
(ds) RNA was shown to amplify T cell–independent antibody 
production to NP-Ficoll by IFN-I–dependent activation of 
follicular B cells (Swanson et al., 2010). We next examined 
whether IFN-I participated in sepsis-induced B cell activation 
Figure 5. Early activation of B cells depends on IFN-I but not 
MyD88 or TRIF signaling, and T cell–independent antibody re-
sponses occur independently of MyD88. (A and B) Early activation of 
splenic B cells 24 h after CLP in WT MyD88/ and TRIF/ mice (A) or in 
129/Sv or IFNAR/ mice (B) as measured by the percentage of CD69+  
B cells. Experiments were performed two independent times with similar 
results with n ≥ 4 mice per group. *, P < 0.05; Ŧ, P < 0.001 with Student’s 
t test comparing Sham versus CLP animals in A or Tukey’s post hoc analy-
sis in B. Error bars represent standard deviation.
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we find that B cells are activated by IFN-I, and MT/ mice 
produce decreased levels of IFN-I–inducible chemokines in-
cluding CXCL10/IP-10, CCL3/MIP-1, CCL5/RANTES, 
and CCL2/MCP-1 (Fig. 2 A and Fig. S3). This suggests that 
deficiency of B cells results in decreased IFN-I–dependent 
chemokine production, which may contribute to failure of 
innate immune-mediated bacterial clearance.
To confirm whether B cells are a relevant target of IFN-I 
and contribute to the overall IFN-I response, we performed 
a pilot study where Rag1/ mice were given 107 B cells 
from 129/Sv or IFNAR/ mice 48 h before sepsis and cyto-
kines were examined. Interestingly, compared with WT mice, 
Rag1/ mice given IFNAR/ B cells possessed significantly 
lower levels of the IFN-I–inducible chemokines CXCL10/
IP-10, CCL2/MCP1, and CCL3/MIP-1 6 h after sepsis. 
This IFN-I–inducible response was partially restored when 
Rag1/ mice were given B cells from 129/Sv mice, con-
firming that B cells contribute to the IFN-inducible cytokine 
response. Importantly, we find that the inflammatory cyto-
kines TNF, KC, and IL-6, which are not regulated by IFN-I, 
also follow this similar pattern, indicating that IFN-I– 
activated B cells can also contribute to non–IFN-I inflamma-
tory cytokine production (Fig. 7).
We previously showed that restoring the IFN-I–inducible 
chemokine CXCL10 was sufficient to restore bacterial 
clearance and survival after sepsis in IFNAR/ mice. Given 
that IFN-I contributes to B cell activation in response to 
CLP, we examined whether CXCL10 can improve survival in 
MT/ mice. We find that, similar to results in IFNAR/ 
Rag1/ mice with B220+ B cells also significantly improves 
sepsis survival (Fig. 6 B). Collectively, these data show that 
both T cell–independent B cell function and antibody pro-
duction provide protection during sepsis.
Deficient chemokine response contributes to poor outcome 
in mice lacking B cells
Because it appears that other B cell functions, and not solely 
antibody production, contribute to survival after sepsis, we 
next examined whether the decreased cytokine and chemo-
kine production directly contributed to the decreased survival 
in B cell–deficient mice. We previously found that IFN-I defi-
ciency worsens sepsis outcome by impairing IFN-I–inducible 
chemokine production, resulting in impaired phagocyte- 
mediated host defense (Kelly-Scumpia et al., 2010). In this study, 
Figure 6. Antibody-dependent and -independent B cell function 
contributes to sepsis survival. (A) Blood was collected from untreated 
WT mice and spun down to collect sera. 2 h before CLP, 200 µl of un-
treated WT sera was injected intraperitoneally into MT/ mice. A sur-
vival study was performed comparing WT (closed diamonds, n = 20), MT 
(closed squares, n = 20), and MT + 200 µl WT sera (open triangles,  
n = 20; log rank test, P = 0.018). (B) B220+ B cells were isolated by magnetic 
bead separation from the spleens of WT mice and 107 cells were injected 
retroorbitally 48 h before surgery. A survival study was performed com-
paring Rag1/ (n = 19) with Rag1/ (n = 19) mice that received B cells 
isolated from WT animals (log rank test, P = 0.05). (C) 6 h after CLP, mice 
were injected with 100 ng mouse recombinant CXCL10 (IP-10) or sterile 
saline. Mice were monitored for survival. (Log rank test, P = 0.04; n = 23 
for MT/ and n = 18 for MT/ + CXCL10). Data shown in A, B, and  
C are combined from two independent experiments with similar results.
Figure 7. IFN-I signaling in B cells contributes to cytokine production 
in septic mice. 107 B cells from WT 129/Sv mice or IFNAR/ mice were trans-
ferred into Rag1/ mice. 2 d later, CLP was performed, and 6 and 18 h later, 
plasma was obtained and cytokine responses were evaluated by luminex 
analysis. Dashed lines represent cytokine concentrations in WT mice. *, P < 0.05 
by one-way ANOVA with post hoc analysis by Tukey’s test. The experiment was 
performed once with n = 5 per group. Error bars represent standard deviation.
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not affect B cell activation. Not surprisingly, given the promi-
nent role of IFN-I signaling in MZ and follicular B cell develop-
ment and T cell–dependent and –independent activation (Lien 
et al., 2010; Swanson et al., 2010; Wang et al., 2010), we find 
that IFNAR/ mice do display decreased B cell activation.
We previously found that IFNAR/ mice succumb 
more readily to sepsis as the result of a failure to activate 
phagocytes, resulting in a failure to clear bacteria which can be 
overcome by treatment with the IFN-inducible chemokine 
CXCL10 (Kelly-Scumpia et al., 2010). Interestingly, mice de-
ficient in B cells or both B and T cells demonstrate not only 
decreased inflammatory cytokine production during sepsis but 
also decreased production of IFN-I–inducible chemokines, 
including CCL5, CCL2, CCL3, and CXCL10, suggesting 
that B cells help produce the IFN-I which contributes to their 
own activation as well as the activation of neutrophils during 
sepsis. Similar to IFNAR/ mice, when MT mice are 
treated with an IFN-inducible chemokine, CXCL10, which 
they are deficient in, sepsis survival is improved. Collectively, 
our results show that IFN-I regulates activation of both innate 
and adaptive immune cells during sepsis and production of 
IFN-inducible chemokines and inflammatory cytokines by 
B cells contribute to clearance of bacteria during sepsis.
Both B and T lymphocytes produce long-lived specific 
immune responses to specific antigens and pathogens, which 
are responsible for immune memory. The contribution of 
lymphocytes to more rapid innate immune responses is now 
becoming recognized. Recently, T cells of the adaptive im-
mune system were shown to dampen early inflammatory 
responses to either viral infections or viral (dsRNA) or in-
flammasome activators (Kim et al., 2007; Guarda et al., 2009). 
In this study, we used CLP, a model of polymicrobial sepsis 
which recapitulates many of the human responses to sepsis to 
determine whether the adaptive immune system contributes 
to innate immunity in response to severe bacterial infection. 
Using this model, it was previously found that mice without 
an adaptive immune system display diminished survival, which 
can be improved with repletion of transgenic lymphocytes 
overexpressing antiapoptotic proteins, but whether B cells are 
also protective was not examined (Hotchkiss et al., 1999). We 
find that B cells of the adaptive immune system can contrib-
ute to the early innate immune responses resulting in host 
defense to bacterial sepsis.
The role of T cells in sepsis has not been fully realized and, 
dependent on the model and the severity of the model of 
sepsis used, T cells have been shown to be protective, detri-
mental, or have no effect (Scumpia et al., 2006, 2007; Enoh 
et al., 2007, 2008; Busse et al., 2008; Stromberg et al., 2009). 
In more inflammatory models of sepsis, where shock and 
metabolic dyscrasias predominate, T cells demonstrate a detri-
mental role, whereas in models that develop only a mild to 
moderate shock phenotype and immunoparalysis predomi-
nates, modification of T cells to prevent apoptosis (Hotchkiss 
et al., 1999, 2000) or to co-stimulate T cells (Schwulst et al., 
2006; Scumpia et al., 2007) has no doubt led to protection. 
Likely, the effects of T cells during sepsis lie on a spectrum 
mice, a single dose of CXCL10 2 h after CLP in MT/ 
mice improved survival to near WT levels (Fig. 6 C). This 
data identifies the B cell as a novel contributor to early IIC 
production resulting in improved innate immune responses 
and host defense after the onset of sepsis.
DISCUSSION
Cooperation of the innate and adaptive immune systems is 
necessary to provide protective immunity to pathogens. Clas-
sically, recruited phagocytes, including neutrophils and macro-
phages along with complement, control initial infection by 
producing free radicals and destructive enzymes, whereas 
dendritic cells and other APCs process antigens to present 
them to helper T cells, which coordinate appropriate adaptive 
immune responses. T lymphocytes mediate long-term cell-
mediated immunity, whereas B cells mediate humoral anti-
body-mediated immunity. Both are responses that classically 
require several days to weeks to develop. Consequently, lym-
phocytes were thought of as bystanders during the acute 
phase of infections until instructed by the innate immune sys-
tem to act during the later stages of infection. This model was 
challenged when studies demonstrated that T cell subsets reg-
ulate acute inflammatory responses to viral infection (Kim 
et al., 2007; Zhang et al., 2007). The exact mechanism of 
T cell control of IIC production by innate immune cells has not 
been fully elucidated but seems to involve two distinct mech-
anisms. Naive or effector T cells can attenuate pathological 
inflammation through viral infection or inflammasome acti-
vation, respectively, through direct cell-to-cell contact with 
APCs, likely through cell surface receptors (Kim et al., 2007; 
Guarda et al., 2009). Memory T cells, in contrast, can augment 
inflammatory responses to virus after direct recognition of 
antigen (Strutt et al., 2010). In this study, we demonstrate a 
previously unrecognized role of B cells as key participants in 
the early inflammatory cytokine response during bacterial sepsis. 
B cells are known to secrete cytokines (originally thought to 
stimulate autocrine) and T cell–independent immunoglobu-
lin upon stimulation with TLR agonists such as LPS and CpG 
DNA in vivo and in vitro (Hobbs et al., 1991; Yi et al., 1996; 
Sun et al., 2005). These bacterial products can cross-link the 
B cell receptor and bind to TLRs simultaneously, thus gener-
ating signals needed for cytokine and antibody production 
simultaneously. During bacterial sepsis induced by CLP, 
multiple TLR agonists and other PAMPs are released locally 
and systemically that can directly activate multiple cell types 
including B cells. Without B cells, mice develop an inadequate 
inflammatory response and fail to clear bacteria, resulting in 
increased mortality. Our data suggests that both antibodies 
and a novel contribution of B cells to the early inflammatory 
cytokine response both contribute to the defects seen in 
MT/ and Rag1/ mice.
Both TLR-dependent and TLR-independent signaling are 
integral to infection-induced antibody production (Pasare and 
Medzhitov, 2005; Gavin et al., 2006). In this study, we find 
that bacterial sepsis induces activation of follicular and MZ 
B cells. Interestingly, MyD88 or TRIF deficiency alone does 
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without ligation or puncture. For CLP survival experiments, the model was 
modified to achieve 40–50% mortality by 7 d in WT mice by ligating 
0.75 cm of cecum and puncturing the cecum with a 27-gauge needle.
In some experiments, mice were injected with 10 mg/kg anti-CD20 
antibody (Biogen Idec) or IgG1 isotype control antibody 7 d before surgery. 
Small amounts of blood were obtained from tail veins to ensure mice were 
bled from tail vein and flow cytometry was performed to ensure depletion of 
B cells occurred. Depletion of B220+CD19+ cells was consistently between 
65 and 75%.
Cell purification and cell transfer experiments. For isolation of B cells, 
erythrocyte-depleted single cell suspensions from spleens of C57BL/6, 
129/Sv, and IFNAR/ mice underwent positive selection using the B220-
positive selection kit (Miltenyi Biotec) as per manufacturer protocol. In 
brief, single cell suspensions were incubated with the B220 microbead 
cocktail for 30 min on ice at 107/10 µl of microbeads. Cells were washed 
twice and ran over LS columns using magnets (Miltenyi Biotec) to elimi-
nate the negative fraction. The positive fraction was eluted off column. The 
purity of B220+ cells was 90%. Of the contaminating cells, 2% or less each 
displayed the phenotype of B220CD11b+, B220CD4+, or B220CD8+. 
Of the B220+ cells, 95% of these cells were B220+CD19+CD11b con-
ventional B2 cells and 2 and 1.5% were B220+CD19+CD11b+ and B220+ 
CD19+CD5+CD11b B1 cells, respectively. Approximately 1% demon-
strated the B220+CD19CD11clowCD11b phenotype of plasmacytoid 
dendritic cells. After washing the purified cells, they were placed in sterile 
normal saline at a concentration of 108/ml, and 100 µl was injected retro-
orbitally in lightly anesthetized mice.
Multiplex cytokine analysis. Assessments of cytokine profile were per-
formed using a commercially available multiplexed kit (Milliplex 22-plex or 
10-plex Mouse Cytokine/Chemokine MAP kit; Millipore). Simultaneous 
measurement of 10 or 22 cytokines/chemokines was performed. All assays 
were performed according to the manufacturer’s protocols. Samples were 
diluted 1:1 in the assay buffer provided with the kit and at least two replicate 
wells were plated per sample. Cytokine concentrations were determined using 
BeadView software (Millipore).
Determination of bacterial counts. Peritoneal bacterial counts were de-
termined by culturing 100 µl of serially diluted peritoneal washings on 
sheep’s blood agar plates (Thermo Fisher Scientific) at 37°C in 5% CO2. 
Plates were counted after 24 h of culture.
Flow cytometry. Immediately after being euthanized, blood, BM, and 
spleens were harvested and a single cell suspension was made. Cells were 
washed in PBS, pelleted, and subsequently stained for flow cytometry. Samples 
were acquired and analyzed on a LSRII flow cytometer (BD). At least 2 × 104 
live (Sytox blue) cells were analyzed.
Statistics. Continuous variables were first tested for normality and equality of 
variances. Differences among groups were evaluated by Student’s t test or 
one-way ANOVA with Tukey’s post hoc analysis where stated. Differences 
in survival were determined by the log-rank test performed on Kaplan-Meier 
curves. Significance was determined at the 95% confidence level.
Online supplemental material. Fig. S1 shows that the lack of T cells had 
no effect on survival or the inflammatory response to CLP. Fig. S2 shows that 
repletion of B cells in Rag1/ mice can increase cytokine responses. Fig. S3 
shows that MT/ mice produce fewer IFN-1–inducible genes after CLP 
than WT mice. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101715/DC1.
The studies were supported by grants GM-40586 and GM-81923, awarded by the 
National Institute of General Medical Sciences. K.M. Kelly-Scumpia, M.J. Delano, and 
A.G. Cuenca were supported by a T32 training grant in burns and trauma (T32 GM-
008721-13) awarded by the National Institute of General Medical Sciences.  
whereby the severity of the bacterial infection and the under-
lying strength of the host immune system contribute to how 
T cells participate in sepsis outcome. We chose to use a model 
of mild to moderate shock, whereby the mice develop a 
prominent immunoparalysis, because we feel this more closely 
approaches what is observed in humans clinically where pa-
tients require long ICU stays and are at risk for secondary in-
fections. In this model, although TCR-deficient mice 
displayed a mild defect that could be investigated in future 
studies, we found that the predominant cell type of the adaptive 
immune system contributing to the early IIC response were 
B cells so we chose to further explore this novel finding.
Our studies show that B lymphocytes are an adaptive 
immune cell type needed to improve outcome and cytokine 
production and reduce bacteremia in response to sepsis. Using 
mice deficient in B and T cells (Rag1/), mice deficient in 
CD4+ and CD8+ T cells (TCR-//), and mice deficient 
in B cells (µMT/), we show that there is a prominent effect 
of the loss of B cells on host innate immune responses through 
the attenuation of the early IIC response. µMT/ mice failed 
to produce the usual increase in cytokines seen after sepsis 
and exhibited more peritoneal bacteremia. Survival of sepsis 
was partially restored by either the transfer of WT serum 
containing immunoglobulins or the transfer of B cells before 
their ability to produce significant levels of antibodies, sug-
gesting that a B cell function separate from antibody produc-
tion is participating in sepsis survival. Importantly, cytokine 
levels could be improved in Rag1/ mice by the adoptive 
transfer of 107 WT B220+ B cells that were able to respond to 
endogenous IFN-I and produce IFN-I–dependent chemo-
kines but not by IFNAR/ B cells. Similarly, administration 
of an IFN-I–dependent chemokine IP-10/CXCL10 to MT/ 
mice, a cytokine which these mice are deficient in, 2 h after 
sepsis initiation, was able to restore survival. These data sug-
gest that the loss of these IFN-I–dependent chemokines pro-
duced by B cells may play a pathogenic role in patients taking 
potent immunosuppressive agents to prevent transplant rejec-
tion or for autoimmune disorders, rendering them susceptible 
to sepsis as a result of this inability to completely induce this 
protective host response.
MATERIALS AND METHODS
Mice. All experiments were approved by the Institutional Animal Care and 
Use Committees at the University of Florida College of Medicine. B6.129S2-
Igh-6tm1Cgn/J (MT/) and B6.129P2-Tcrtm1MomTcrTm1Mom (TCR-
// mice) backcrossed at least 10 generations to a C57BL/6J background, 
C57BL/6J.Rag1Tm1Mom (Rag1/), C57BL/6J-Ticam1Lps2/J (TRIF/), and 
C57BL/6 mice were purchased from The Jackson Laboratory. 129/Sv and 
IFNAR1/ mice were purchased from B&K Universal and were a gift from 
W. Reeves (University of Florida College of Medicine, Gainesville, FL). 
MyD88/ were a gift of A. Ayala (Brown University, Providence, RI).
Mouse infection models. For induction of polymicrobial sepsis, mice 
underwent CLP or a sham procedure, as previously described (Delano et al., 
2007), to obtain a mortality of 10–20% in control mice by 7 d. In brief, a 
laparotomy was performed, the cecum was isolated, and 0.5 cm of cecum 
was ligated below the ileocecal valve and punctured through and through 
with a 27-gauge needle. Sham operation was performed by isolating the cecum 
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